Total Payments
$21,645
2024 Payments
$114.72
Companies
39
Transactions
577
Medicare Patients
1,701
Medicare Billing
$203,112
Payment Breakdown by Category
Food & Beverage$21,008 (97.1%)
Travel$562.00 (2.6%)
Education$74.87 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,008 | 565 | 97.1% |
| Travel and Lodging | $562.00 | 1 | 2.6% |
| Education | $74.87 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,791 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,962 | 114 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $2,296 | 105 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,288 | 64 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,296 | 19 | $0 (2019) |
| ABBVIE INC. | $1,167 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $894.42 | 20 | $0 (2022) |
| Amgen Inc. | $874.70 | 21 | $0 (2019) |
| Novo Nordisk Inc | $642.42 | 29 | $0 (2023) |
| Gilead Sciences, Inc. | $636.20 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114.72 | 5 | Merck Sharp & Dohme LLC ($43.11) |
| 2023 | $579.18 | 19 | Janssen Pharmaceuticals, Inc ($207.22) |
| 2022 | $1,768 | 47 | ABBVIE INC. ($683.67) |
| 2021 | $1,691 | 67 | Boehringer Ingelheim Pharmaceuticals, Inc. ($376.99) |
| 2020 | $1,025 | 44 | AstraZeneca Pharmaceuticals LP ($338.43) |
| 2019 | $3,151 | 105 | Boehringer Ingelheim Pharmaceuticals, Inc. ($735.38) |
| 2018 | $5,597 | 137 | Boehringer Ingelheim Pharmaceuticals, Inc. ($768.47) |
| 2017 | $7,719 | 153 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,718) |
All Payment Transactions
577 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: DIABETES | ||||||
| 01/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: DIABETES | ||||||
| 09/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/03/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.02 | General |
| 07/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $112.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: DIABETES | ||||||
| 03/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/08/2022 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 80 | 208 | $52,800 | $16,601 |
| 2022 | 6 | 414 | 768 | $128,163 | $38,633 |
| 2021 | 9 | 590 | 1,097 | $199,254 | $64,716 |
| 2020 | 7 | 617 | 1,347 | $278,685 | $83,162 |
Total Patients
1,701
Total Services
3,420
Medicare Billing
$203,112
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 160 | $48,000 | $16,012 | 33.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 48 | $4,800 | $589.28 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 180 | $54,000 | $18,724 | 34.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 127 | $34,925 | $8,443 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 20 | 23 | $17,250 | $4,165 | 24.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 23 | $6,900 | $4,146 | 60.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 265 | 372 | $10,788 | $2,659 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 43 | $4,300 | $495.64 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 229 | $68,750 | $25,550 | 37.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 156 | $42,900 | $10,703 | 24.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 37 | 49 | $36,750 | $9,806 | 26.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 36 | $10,800 | $6,726 | 62.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 39 | $13,600 | $6,129 | 45.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 310 | 443 | $12,404 | $3,257 | 26.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 56 | 100 | $10,000 | $1,332 | 13.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $3,250 | $1,164 | 35.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 21 | 32 | $800.00 | $48.58 | 6.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 289 | $86,700 | $27,863 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 44 | 298 | $81,950 | $20,310 | 24.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 59 | 83 | $62,250 | $16,412 | 26.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 51 | 73 | $21,900 | $13,666 | 62.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 278 | 432 | $12,960 | $3,274 | 25.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 67 | 115 | $11,500 | $1,549 | 13.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 30 | 57 | $1,425 | $88.12 | 6.2% |
About Dr. Daniel Anghel, MD
Dr. Daniel Anghel, MD is a Cardiovascular Disease healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033190046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Anghel, MD has received a total of $21,645 in payments from pharmaceutical and medical device companies, with $114.72 received in 2024. These payments were reported across 577 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($21,008).
As a Medicare-enrolled provider, Anghel has provided services to 1,701 Medicare beneficiaries, totaling 3,420 services with total Medicare billing of $203,112. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location East Meadow, NY
- Active Since 11/08/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033190046
Products in Payments
- JARDIANCE (Drug) $2,865
- FARXIGA (Drug) $2,240
- XARELTO (Drug) $2,097
- ENTRESTO (Drug) $2,012
- ELIQUIS (Drug) $1,075
- UBRELVY (Drug) $808.21
- PRALUENT (Drug) $758.03
- PRADAXA (Drug) $576.51
- Repatha (Biological) $566.01
- Ranexa (Drug) $559.54
- PRALUENT ALIROCUMAB INJECTION (Biological) $487.15
- Victoza (Drug) $316.96
- BYDUREON (Drug) $314.78
- BELSOMRA (Drug) $302.44
- LEQVIO (Drug) $284.11
- SOLIQUA (Drug) $280.70
- Corlanor (Drug) $280.51
- Vascepa (Drug) $280.50
- ZENPEP (Drug) $260.78
- TOUJEO (Drug) $257.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in East Meadow
Alan Gass, Md, MD
Cardiovascular Disease — Payments: $283,417
Cardiovascular Disease $283,417
Mr. Leon Mullen, Md, MD
Cardiovascular Disease — Payments: $5,705
Cardiovascular Disease $5,705
Dr. Ofek Hai, D.o, D.O
Cardiovascular Disease — Payments: $479.01
Cardiovascular Disease $479.01
Barry Saul, Md, MD
Cardiovascular Disease
Cardiovascular Disease